
Welcome to DIA
237311318
1964
Washington, DC 20036 United States
diaglobal.org
DrugInfoAssn
DrugInformationAssociation
184921
Podobné organizace
The Diabesity Institute |
|
Molecular Psychiatry Association Inc |
|
National Hidta Directors Association |
|
National Association of Drug Diversion Investigators Inc |
|
Digital Pathology Association Foundation Inc |
Podobné organizace global
More from Washington
LIVING WAGES OF WASHINGTON |
|
Rappahannock County Farm Tour |
|
Zenith Community Arts Foundation |
|
CAIR-FOUNDATION INC |
|
COMMITTEE IN SOLIDARITY WITH THE PEOPLE OF EL SALVADOR |
Similar traffic
Casualty Actuarial Society |
|
Casualty Actuaries of New England |
|
Clarion Project, INC. |
|
Norman B Leventhal Map & Education Center Inc |
|
Graceland University |
Similar social media (9691)
QUALITY HEALTH AFRICA9693 |
|
HANDLEY REGIONAL LIBRARY ENDOWMENT FUND9692 |
|
Esophageal Cancer Action Network Inc9698 |
|
Grateful Hearts Senior Dog Rescue9694 |
|
DIVERSIONARY THEATRE PRODUCTIONS INC9694 |
News

We're proud to celebrate Mike Rosenblatt, MD, recipient of the Chair, Fellows of DIA! The Fellows of DIA represent our longest standing, most highly committed members. Fellowship is an honorary recognition, bestowed on less than 1% of DIA's members, who have demonstrated active support of the advancement of global healthcare through DIA's neutral forum. Dr. Mike Rosenblatt is a physician-scientist and executive recognized for shaping health innovation across academia, government, and industry. Join us in honoring his achievements and those of other colleagues at the 2025 DIA Inspire Awards Gala: a night to be remembered! Be there! https://ow.ly/P0Sc50W133Q #DIA2025 #FellowsofDIA #HealthcareLeadership #Innovation (fb)

The world is watching: How will FDA leadership shape the future of innovation, access, and global drug development? At #DIA2025, we’re honored to welcome Dr. Marty Makary, newly appointed U.S. FDA Commissioner, for a major address to the global life sciences community. As regulatory frameworks evolve and the pressure to deliver safe, effective, and affordable therapies grows—drug developers, innovators, and health systems worldwide are eager to understand Dr. Makary’s vision: What’s next for scientific innovation and real-world evidence? How will pricing and access balance with sustainable innovation? What changes in review and structure could impact the pipeline? Regardless of where you sit in the world, this is a moment of clarity, strategy, and collaboration—and your opportunity to engage with the ideas shaping the future of global health. https://ow.ly/l7bP50W12Yy #DIA2025 | June 15–19 | Washington, DC (fb)
